David Cory

David Cory

Amministratore Delegato presso CASI PHARMACEUTICALS, INC.
62 anni
Health Technology
Consumer Services

Profilo

David A. Cory was the founder of Eiger BioPharmaceuticals, Inc. (2008), holding the title of President, Chief Executive Officer & Director.
Mr. Cory is also the founder of CoTherix, Inc. Mr. Cory is the Chief Executive Officer & Director at CASI Pharmaceuticals, Inc. since 2025.
Former positions included Chief Executive Officer at DiObex, Inc. (2007-2008), President, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. (2009-2016), Chief Executive Officer & Director at LIB Therapeutics LLC (2023-2025), and Principal at The Upjohn Co., Glaxo Wellcome, Inc., and GlaxoSmithKline LLC.
Education includes an MBA from the University of Maryland University College and an undergraduate degree from The James L.
Winkle College of Pharmacy.

Posizioni attive di David Cory

SocietàPosizioneInizio
CASI PHARMACEUTICALS, INC. Amministratore Delegato 21/07/2025

Precedenti posizioni note di David Cory

SocietàPosizioneFine
Amministratore Delegato 01/01/2025
EIGER BIOPHARMACEUTICALS Fondatore 14/12/2022
Amministratore Delegato 01/03/2016
Amministratore Delegato 01/01/2008
Presidente 01/01/2006
Vedi nel dettaglio l'esperienza di David Cory

Formazione di David Cory

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

42

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. David Cory
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA